MARKET WIRECNBC • 3h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why SGHT Stock surged +3.57% Today — RQD Quant Desk Flash
$9.57 +3.57% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $9.61
Sight Sciences Inc. (SGHT) carries a Roarable Rating of D- (Sell) with 38/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $527.2M
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $9.61 (+0.45%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (38/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.8% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-9% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SGHT)Realized 20D OHLCV Swing Band: ±11.5%
Deterministic 5-Pillar Attribution (38/100 Composite)
🔍 WHY SGHT SCORES 38/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+12/20 pts (32% of score)
20D Institutional Volume Accumulation (±11.5% realized swing band)
▲ #2 Bullish Driver: Macro Regime Fit+11/20 pts (29% of score)
FRED Regime × Technicals: 98% of 52W Range • RSI-14 at 59.3 (BULLISH MOMENTUM)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$8.89-6.9% Next Q
30
Q2 (-2Q)Grade E$8.28+8.6% Next Q
33
Q3 (-1Q)Grade E$8.99+6.5% Next Q
35
CurrentGrade D-$9.57-7.8% Hist 90D α
38
Trajectory: E (30) → D- (38)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a SGHT Turnaround Squeeze
While SGHT currently carries a cautious 38/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($8.59) and Max Pain ($10.05) forces dealer call-delta covering toward $10.28.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $SGHT• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “SGHT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why SGHT Stock surged +3.57% Today — RQD Quant Desk Flash
Sight Sciences Inc. (SGHT) surged +3.57% to $9.57, trading at 98% of its 52-week range ($3.38 – $9.71). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 98% of its 52-week range ($3.38 – $9.71) with RSI-14 at 59.3 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±11.5% around $9.57 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 86.2% gross margin and $0 annual free cash flow.
Live SGHT Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SGHT)
- ✓Walkthrough of SGHT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
SGHT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +133.99%▲ ASCENDING CHANNEL
2026-10-30O $9.60H $9.60L $9.23C $9.57VOL 267.5K
RES: $10.42SUP: $4.78SMA50: $8.59SMA200: $5.99
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
SGHT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. -3.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on SGHT today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for SGHT. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for SGHT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SGHT)
Health Care Rank #706 of 1016
⚔️ ANGO vs SGHT Full Matrix →
1. Head-to-Head Health Care Peer Comparison (SGHT vs. ANGO, RCEL, SENS, DCTH)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Sight Sciences Inc. (SGHT) ranks #706 by composite RQD confidence (38/100, grade D-) and #437 by equity capitalization ($527.2M). Within this direct 5-issuer industry benchmark cohort, SGHT leads on earnings valuation at N/A trailing P/E, while DCTH leads on capital efficiency and profitability with 0.8% ROIC and 86.2% gross margin. DCTH currently holds the highest overall quantitative score in the immediate peer group at 57/100 (D+) compared with SGHT at 38/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| SGHT
ACTIVE
Sight Sciences Inc. | D- | 38/100 | — | 86.2% | -35.0% | +3.57% | $527.2M | Benchmark Subject |
| ANGO AngioDynamics Inc. | D | 50/100 | — | 54.6% | -23.4% | +1.81% | $519.4M | /ango-vs-sght → |
| RCEL Avita Medical Inc. | D | 44/100 | — | 82.1% | -35.0% | +1.27% | $516.8M | /rcel-vs-sght → |
| SENS Senseonics Holdings Inc. | D- | 38/100 | — | 44.7% | -35.0% | +4.39% | $515.5M | /sens-vs-sght → |
| DCTH Delcath Systems Inc. | D+ | 57/100 | — | 86.2% | 0.8% | -1.48% | $508.0M | /dcth-vs-sght → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001531177In its most recent audited fiscal period (FY2025, filed 2025-12-31), Sight Sciences Inc. (SGHT) reported GAAP revenue of $77.4M (-3.1% vs. FY2024 revenue of $79.9M , and -4.6% cumulative change since FY2023) , GAAP net income of -$38.4M, operating cash flow of -$29.7M, and free cash flow of -$29.9M (-31.6% YoY). On the balance sheet, SGHT closed FY2025 with $115.3M in total assets against $40.3M in total debt (Altman Z-Score: 2.16, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $77.4M | -$38.4M | -$29.7M | -$29.9M | $115.3M | $40.3M |
| FY2024 (FY) | 2024-12-31 | $79.9M | -$51.5M | -$22.4M | -$22.7M | $142.8M | $39.4M |
| FY2023 (FY) | 2023-12-31 | $81.1M | -$55.5M | -$47.2M | -$47.2M | — | — |
3. SGHT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs SGHT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Sight Sciences Inc. (NASDAQ: SGHT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $9.57 (+3.57% 1D, market cap $527.2M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, SGHT ranks #706 in composite RQD confidence.
How does SGHT compare to ANGO and RCEL in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), SGHT carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 86.2%, and ROIC of -35.0%. By comparison, ANGO (AngioDynamics Inc.) holds a D grade (50/100 RQD, P/E N/A, ROIC -23.4%, cap $519.4M) and RCEL (Avita Medical Inc.) posts a D grade (44/100 RQD, P/E N/A, ROIC -35.0%, cap $516.8M). Among the 5-stock peer group, SGHT leads on earnings multiple (N/A) while DCTH leads on capital efficiency (0.8% ROIC).
What are the biggest fundamental strengths and SEC risk factors for SGHT?
Per SGHT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001531177), Sight Sciences Inc. generated $77.4M in revenue (-3.1% YoY), -$38.4M in net income, and -$29.9M in free cash flow against $115.3M in total assets and $40.3M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is SGHT trading relative to its 50-day, 200-day, and 52-week technical levels?
SGHT last traded at $9.57 (+3.57% on volume of 346,467 shares), positioning the stock +11.41% above its 50-day simple moving average ($8.59) and +59.77% above its 200-day simple moving average ($5.99). Across its 52-week range of $3.38 to $9.71, SGHT sits at the 97.8% percentile with a 14-day RSI of 59.3 (BULLISH MOMENTUM) and an implied next-earnings move of ±11.5% ($8.47 to $10.67).
SGHT Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is SGHT stock moving today?
Why SGHT Stock surged +3.57% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.